{"cluster": 37, "subcluster": 8, "abstract_summ": "As a headache expert and based on my own personal clinical case, headaches related to COVID\u201019 can be classified in the 2 phases of the disease.Neither the virus nor potential risk factors for seizures seem to be significant risks for the occurrence of acute symptomatic seizures in COVID\u201019.BACKGROUND AND PURPOSE: Although the main clinical features of COVID\u201019 infection are pulmonary, several associated neurological signs, symptoms and diseases are emerging.This headache is probably related to the cytokine storm that some patients suffer and it could be framed under the ICHD3 headache of Headache attributed to other non\u2010infectious inflammatory intracranial disease.CONCLUSIONS: Several headaches can appear during COVID\u201019 infection.Acute headache attributed to systemic viral infection, primary cough headache, tension\u2010type headache and headache attributed to heterophoria can appear in the first phase (the influenza\u2010like phase); and headache attributed to hypoxia and a new headache, difficult to fit into the ICHD3, can appear if the second phase (the cytokine storm phase) occurs.", "title_summ": "Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter studyThe international EAN survey on neurological symptoms in patients with COVID\u201019 infectionHeadaches During COVID\u201019:My Clinical Case and Review of the Literature", "title_abstract_phrases": "Neither the virus nor potential risk factors for seizures seem to be significant risks for the occurrence of acute symptomatic seizures in COVID\u201019.The international EAN survey on neurological symptoms in patients with COVID\u201019 infectionBACKGROUND AND PURPOSE: Although the main clinical features of COVID\u201019 infection are pulmonary, several associated neurological signs, symptoms and diseases are emerging.Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.OBJECTIVE The emergence of coronavirus disease 2019 (COVID-19) presents a challenge for neurologists caring for patients with preexisting neurologic conditions hospitalized for COVID-19 or for evaluation of patients who suffer neurologic complications during COVID-19 infection.As a headache expert and based on my own personal clinical case, headaches related to COVID\u201019 can be classified in the 2 phases of the disease.This survey justifies setting up a prospective registry to better capture the prevalence of patients with neuro COVID\u201019, neurological disease characteristics and the contribution of neurological manifestations to outcome.CONCLUSIONS: Several headaches can appear during COVID\u201019 infection."}